ZNF382 is frequently downregulated by promoter methylation in HBV-associated hepatocellular carcinoma (HCC), and decreased expression of ZNF382 is closely linked to poor survival in patients with early HCC. The gene discussed is ZNF382; the disease is hepatocellular carcinoma.